Switch to:
More From Other Websites
Puma (PBYI) Expands Study Cohort for Lead Candidate PB272 Jan 09 2017
Vertex Pharma Issues Disappointing 2017 Orkambi Outlook Jan 09 2017
ARENA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Jan 06 2017
Arena Pharmaceuticals Dumps Belviq Weight Loss Drug Jan 06 2017
Genocea Stock Up on Positive Genital Herpes Infections Data Jan 06 2017
Biogen Licenses Amunix's XTEN Technology for Factor IX Drug Jan 06 2017
Arena, Eisai Modify Marketing & Supply Agreement for Belviq Jan 05 2017
Evoke Diabetic Gastroparesis Drug Gimoti Positive in Phase III Jan 05 2017
Allergan (AGN) Liletta sNDA Accepted for Review in the U.S. Jan 05 2017
Arena Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ARNA-US :... Jan 05 2017
Eisai Acquires All Global Development and Marketing Rights for Chronic Weight Management Treatment... Jan 04 2017
ARENA PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Jan 04 2017
Arena Pharmaceuticals and Eisai Amend Marketing and Supply Agreement for BELVIQ Globally Jan 04 2017
Clovis Declares Pricing of Upsized Offering of Common Stock Jan 04 2017
Allergan Natrelle Inspira Breast Implants Approved in the U.S. Jan 04 2017
Arena Pharmaceuticals, Inc. – Value Analysis (NASDAQ:ARNA) : December 27, 2016 Dec 27 2016
Arena Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ARNA-US :... Dec 26 2016
Eisai and Arena Pharmaceuticals Announce Regulatory Approval of BELVIQ® (lorcaserin HCl) in Brazil Dec 19 2016
ETFs with exposure to Arena Pharmaceuticals, Inc. : December 19, 2016 Dec 19 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK